BioHealth News Archive
Sucampo hires former Zyngenia chief Peter Kiener as CSO – Washington Business Journal
Sucampo Pharmaceuticals Inc. on Thursday named Peter Kiener — whose past roles includes CEO of Zyngenia and head of biologics R&D for MedImmune —…
Read More
New research offers hope in treating sleeping sickness – ScienceBlog.com
In early drug discovery, you need a starting point, says Northeastern University associate professor of chemistry and chemical biology Michael Pollastri. In a new…
Read More
Growing a Blood Vessel in a Week – ScienceBlog.com
The technology for creating new tissues from stem cells has taken a giant leap forward. Two tablespoons of blood are all that is needed…
Read More
Qiagen launches new features for bioinformatics solutions
Qiagen has announced the introduction of expanded functionality for its range of bioinformatics workflow solutions. New capabilities for the Ingenuity Variant Analysis and CLC…
Read More
Predictive Medicine Depends on Analytics – Harvard Business Review
Regression models, Monte Carlo simulations, and other methods for predicting what’s around the corner have been in use for decades. It’s only recently, though,…
Read More
Roche outlines $3bn expansion for its Basel site – PMLiVE
Roche plans to spend around $3bn updating and expanding its Basal site, home to the Swiss company's headquarters, over the next 10 years. The…
Read MoreHHS Secretary announces $840 million initiative to improve patient care and lower costs
New initiative will support networks that help doctors access information and improve health outcomes Health and Human Services Secretary Sylvia M. Burwell today announced…
Read More
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda Pharmaceutical Company Limited (Takeda) today announced that on October 17, 2014, they entered…
Read More
5 charts illustrate the “evolve or die” crisis facing the medical device industry
It’s not just the FDA that is making life difficult for medical device companies. Executives are having to follow sales opportunities as medical care…
Read More
Surgeons, say goodbye to stitches or staples – ZipLine has an alternative
Stapling up skin post-surgery is pretty much the norm to quickly seal up wounds, but it runs a risk of infection and injury from the extra…
Read More
How a Univ. of Md. policy will help non-tenure faculty land promotions – The Diamondback : News
Colleen Worthington has been working at this university for more than 24 years. It wasn’t until this year, however, that she received her first…
Read More
Health department launches TB trial with emocha app – Technical.ly Baltimore
Tuberculosis is both tough to treat and medically cumbersome to manage. Under directly observed therapy, a medical professional has to watch a patient take…
Read More
Army awards Baltimore’s Profectus BioSciences $8.5M for Ebola vaccine work – Baltimore Business Journal
Baltimore biopharmaceutical company Profectus BioSciences Inc. has received a three-year, $8.5 million grant from the U.S. Army for work on an Ebola vaccine. Profectus…
Read More
The HHS IDEA Lab – What is it?
Earlier this year, the Secretary of the Department of Health and Human Services (HHS) launched the HHS IDEA Lab. With it, we unveiled a…
Read More
Mass General, MIT form alliance to address three ‘major challenges’ in healthcare
Massachusetts General Hospital and MIT have formed a $3 million strategic alliance in an attempt to address three “major challenges” that persist in healthcare:…
Read More